Vasa Denticity Share Price
Sector: Medical Equipment & Supplies
603.45 +3.35 (0.56%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
596.10
Today’s High
606.00
52 Week Low
480.00
52 Week High
840.00
Key Metrics
- Market Cap (In Cr) 966.5
- Beta -
- Div. Yield (%) -
- P/B 7.57
- TTM P/E -
- Sector P/E 22.11
Vasa Denticity Analysis
Price Analysis
-
1 Week0.02%
-
3 Months4.65%
-
6 Month-17.52%
-
YTD-18.01%
-
1 Year14.44%
Vasa Denticity News
Breakout stocks to buy or sell: Sumeet Bagadia recommends three stocks to buy
1 min read . 30 Sep 2024Multibagger IPOs: 5 SME issues that listed in June are up between 125% to 190%
3 min read . 08 Jul 2023Ashish Kacholia buys stake in this multibagger SME IPO. Do you own?
1 min read . 01 Jul 2023Vasa Denticity IPO opens next week. GMP, price, other details. Apply or avoid?
2 min read . 20 May 2023Vasa Denticity Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 249.37
- Selling/ General/ Admin Expenses Total
- 14.45
- Depreciation/ Amortization
- 1.73
- Other Operating Expenses Total
- 36.96
- Total Operating Expense
- 228.17
- Operating Income
- 21.19
- Net Income Before Taxes
- 23.12
- Net Income
- 16.97
- Diluted Normalized EPS
- 10.45
- Period
- 2025
- Total Assets
- 151.22
- Total Liabilities
- 18.7
- Total Equity
- 132.52
- Tangible Book Valueper Share Common Eq
- 76.37
- Period
- 2025
- Cashfrom Operating Activities
- -3.55
- Cashfrom Investing Activities
- -42.68
- Cashfrom Financing Activities
- 46.81
- Net Changein Cash
- 0.57
- Period
- 2024
- Total Revenue
- 171.88
- Selling/ General/ Admin Expenses Total
- 11.77
- Depreciation/ Amortization
- 1
- Other Operating Expenses Total
- 15.55
- Total Operating Expense
- 153.81
- Operating Income
- 18.08
- Net Income Before Taxes
- 19.41
- Net Income
- 15.08
- Diluted Normalized EPS
- 9.73
- Period
- 2024
- Total Assets
- 85.74
- Total Liabilities
- 17.39
- Total Equity
- 68.35
- Tangible Book Valueper Share Common Eq
- 41.58
- Period
- 2024
- Cashfrom Operating Activities
- -11.45
- Cashfrom Investing Activities
- -22.36
- Cashfrom Financing Activities
- 36.42
- Net Changein Cash
- 2.61
- Period
- 2023
- Total Revenue
- 123.27
- Selling/ General/ Admin Expenses Total
- 8.02
- Depreciation/ Amortization
- 0.54
- Other Operating Expenses Total
- 12.04
- Total Operating Expense
- 113.45
- Operating Income
- 9.82
- Net Income Before Taxes
- 9.95
- Net Income
- 7.6
- Diluted Normalized EPS
- 4.75
- Period
- 2023
- Total Assets
- 27.75
- Total Liabilities
- 11.92
- Total Equity
- 15.83
- Tangible Book Valueper Share Common Eq
- 11.74
- Period
- 2023
- Cashfrom Operating Activities
- 1.74
- Cashfrom Investing Activities
- -1.02
- Cashfrom Financing Activities
- -0.13
- Net Changein Cash
- 0.59
- Period
- 2022
- Total Revenue
- 76.92
- Selling/ General/ Admin Expenses Total
- 4.7
- Depreciation/ Amortization
- 0.31
- Other Operating Expenses Total
- 8.93
- Total Operating Expense
- 71.65
- Operating Income
- 5.27
- Net Income Before Taxes
- 5.01
- Net Income
- 5
- Diluted Normalized EPS
- 3.12
- Period
- 2022
- Total Assets
- 19.14
- Total Liabilities
- 13.41
- Total Equity
- 5.73
- Tangible Book Valueper Share Common Eq
- 3.58
- Period
- 2022
- Cashfrom Operating Activities
- 0.4
- Cashfrom Investing Activities
- -0.57
- Cashfrom Financing Activities
- 0.79
- Net Changein Cash
- 0.61
- Period
- 2021
- Total Revenue
- 40.07
- Selling/ General/ Admin Expenses Total
- 2.75
- Depreciation/ Amortization
- 0.09
- Other Operating Expenses Total
- 3.06
- Total Operating Expense
- 39.66
- Operating Income
- 0.41
- Net Income Before Taxes
- 0.44
- Net Income
- 0.33
- Diluted Normalized EPS
- 0.2
- Period
- 2021
- Total Assets
- 6.91
- Total Liabilities
- 6.31
- Total Equity
- 0.6
- Tangible Book Valueper Share Common Eq
- 0.35
- Period
- 2021
- Cashfrom Operating Activities
- -0.46
- Cashfrom Investing Activities
- -1.29
- Cashfrom Financing Activities
- 1.26
- Net Changein Cash
- -0.48
- Period
- 2020
- Total Revenue
- 30.42
- Selling/ General/ Admin Expenses Total
- 3.1
- Depreciation/ Amortization
- 0.08
- Other Operating Expenses Total
- 2.77
- Total Operating Expense
- 30.24
- Operating Income
- 0.18
- Net Income Before Taxes
- 0.09
- Net Income
- 0.09
- Diluted Normalized EPS
- 0.06
- Period
- 2020
- Total Assets
- 4.82
- Total Liabilities
- 4.55
- Total Equity
- 0.27
- Tangible Book Valueper Share Common Eq
- 0.14
- Period
- 2020
- Cashfrom Operating Activities
- 0.8
- Cashfrom Investing Activities
- -0.41
- Cashfrom Financing Activities
- -0.06
- Net Changein Cash
- 0.32
- Period
- 2025-03-31
- Total Revenue
- 73.02
- Selling/ General/ Admin Expenses Total
- 4.4
- Depreciation/ Amortization
- 0.59
- Other Operating Expenses Total
- 13.37
- Total Operating Expense
- 67.22
- Operating Income
- 5.8
- Net Income Before Taxes
- 5.98
- Net Income
- 4.21
- Diluted Normalized EPS
- 2.54
- Period
- 2025-03-31
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -3.55
- Cashfrom Investing Activities
- -42.68
- Cashfrom Financing Activities
- 46.81
- Net Changein Cash
- 0.57
- Period
- 2024-09-30
- Total Revenue
- 58.3
- Selling/ General/ Admin Expenses Total
- 3.31
- Depreciation/ Amortization
- 0.28
- Other Operating Expenses Total
- 7.75
- Total Operating Expense
- 52.19
- Operating Income
- 6.11
- Net Income Before Taxes
- 7.09
- Net Income
- 5.37
- Diluted Normalized EPS
- 3.35
- Period
- 2024-09-30
- Total Assets
- 98.05
- Total Liabilities
- 20.72
- Total Equity
- 77.33
- Tangible Book Valueper Share Common Eq
- 46.37
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -9.2
- Cashfrom Investing Activities
- 7.18
- Cashfrom Financing Activities
- -0.08
- Net Changein Cash
- -2.09
- Period
- 2024-06-30
- Total Revenue
- 53.54
- Selling/ General/ Admin Expenses Total
- 2.8
- Depreciation/ Amortization
- 0.37
- Other Operating Expenses Total
- 4.69
- Total Operating Expense
- 49.29
- Operating Income
- 4.25
- Net Income Before Taxes
- 4.57
- Net Income
- 3.4
- Diluted Normalized EPS
- 2.12
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 95.06
- Selling/ General/ Admin Expenses Total
- 4.4
- Depreciation/ Amortization
- 0.55
- Other Operating Expenses Total
- 10.89
- Total Operating Expense
- 83.4
- Operating Income
- 11.66
- Net Income Before Taxes
- 11.78
- Net Income
- 8.8
- Diluted Normalized EPS
- 5.49
- Period
- 2024-03-31
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -11.45
- Cashfrom Investing Activities
- -22.36
- Cashfrom Financing Activities
- 36.42
- Net Changein Cash
- 2.61
- Period
- 2023-09-30
- Total Revenue
- 76.82
- Selling/ General/ Admin Expenses Total
- 4.43
- Depreciation/ Amortization
- 0.45
- Other Operating Expenses Total
- 7.63
- Total Operating Expense
- 70.43
- Operating Income
- 6.39
- Net Income Before Taxes
- 7.63
- Net Income
- 6.28
- Diluted Normalized EPS
- 4.19
- Period
- 2023-09-30
- Total Assets
- 74.77
- Total Liabilities
- 15.23
- Total Equity
- 59.55
- Tangible Book Valueper Share Common Eq
- 37.03
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -8.89
- Cashfrom Investing Activities
- -25.73
- Cashfrom Financing Activities
- 36.82
- Net Changein Cash
- 2.2
- Period
- 2023-03-31
- Total Revenue
- 35.98
- Selling/ General/ Admin Expenses Total
- 1.85
- Depreciation/ Amortization
- 0.17
- Other Operating Expenses Total
- 3.9
- Total Operating Expense
- 33.2
- Operating Income
- 2.78
- Net Income Before Taxes
- 2.96
- Net Income
- 2.58
- Diluted Normalized EPS
- 1.61
- Period
- 2023-03-31
- Total Assets
- 27.75
- Total Liabilities
- 11.92
- Total Equity
- 15.83
- Tangible Book Valueper Share Common Eq
- 11.74
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 1.74
- Cashfrom Investing Activities
- -1.02
- Cashfrom Financing Activities
- -0.13
- Net Changein Cash
- 0.59
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Vasa Denticity Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Poly Medicure
- 2259.25
- -27.25
- -1.19
- 3350
- 1590.25
- 22892.01
- Vasa Denticity
- 603.45
- 3.35
- 0.56
- 840
- 480
- 966.5
- Mallcom (india)
- 1130
- -9.4
- -0.82
- 1780
- 937.2
- 703.52
- Nureca
- 255.9
- 5
- 1.99
- 447
- 198
- 255.9
- Yash Optics & Lens
- 82
- 0.75
- 0.92
- 121.85
- 72.6
- 203.08
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Poly Medicure
- 66.22
- 8.27
- 16.63
- 18.03
- Vasa Denticity
- 57.75
- 7.57
- 28.66
- 6.79
- Mallcom (india)
- 18.72
- 2.37
- 19.98
- 9.57
- Nureca
- 302.04
- 1.32
- 9.56
- 10.5
- Yash Optics & Lens
- 22.41
- 6.78
- -
- -
Vasa Denticity Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 16-May-25
- Audited Results
- 14-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 16-May-24
- Audited Results
- 03-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Sept-24
- 13-Aug-24
- AGM
- 20-Sept-23
- 03-Aug-23
- AGM



